Scientific, Technical Research and Program Management Support Services for USAMRIID
ID: HT942525R0005Type: Presolicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)ARMY MED RES ACQ ACTIVITYFORT DETRICK, MD, 21702, USA

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; R&D ADMINISTRATIVE EXPENSES (AN14)

Set Aside

8(a) Set-Aside (FAR 19.8) (8A)

Original Source

https://sam.gov/opp/abf823cc5e9f4e2aa831d3abbab049a8/view
Timeline
    Description

    The Department of Defense, through the Defense Health Agency (DHA), is seeking contractors to provide scientific, technical research, and program management support services for the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) at Fort Detrick, Maryland. The procurement aims to fulfill USAMRIID's mission of safeguarding the Warfighter from biological threats and enhancing public health response capabilities, requiring expertise in various scientific disciplines and compliance with stringent laboratory standards. This pre-solicitation notice indicates that proposals will be due by April 3, 2025, with a solicitation forecasted for March 3, 2025. Interested parties can contact Christina Lewis at christina.m.lewis14.civ@health.mil or Jayme Fletcher at jayme.l.fletcher2.civ@health.mil for further information.

    Point(s) of Contact
    Christina Lewis
    christina.m.lewis14.civ@health.mil
    Jayme Fletcher
    jayme.l.fletcher2.civ@health.mil
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Scientific, Technical Research and Program Management Support Services for USAMRIID
    Currently viewing
    Presolicitation
    Similar Opportunities
    Request For Information - Administrative, Scientific, and Technical Support Services of the Chemical, Biological Radiological, & Nuclear Defense Research Coordinating Office
    Dept Of Defense
    The Department of Defense, through the Army Medical Research Acquisition Activity, is seeking information from vendors regarding Administrative, Scientific, and Technical Support Services for the Chemical, Biological, Radiological, and Nuclear Defense Research Coordinating Office (CBRN DCO). The primary objectives include management and administration support, meeting and conference facilitation, research and analysis assistance, and financial support services, all of which require personnel to hold active SECRET clearances. This opportunity is crucial for enhancing defense capabilities through coordinated medical research and management expertise, with a contract period of one base year and up to four option years anticipated. Interested vendors must submit a Capability Statement by February 4, 2025, to Ms. Elizabeth O'Hara at elizabeth.m.ohara3.civ@health.mil, as this RFI does not imply a commitment to procure services nor will costs incurred in response be reimbursable.
    Notice of Intent to Sole Source - Aptamer Library Generation Services for USAMRIID
    Dept Of Defense
    The Department of Defense, through the U.S. Army Medical Research Acquisition Activity (USAMRAA), intends to award a sole source contract to Aptagen, LLC for the generation of DNA Aptamer Libraries to support the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). The contract will require the generation of two DNA aptamer libraries annually, consisting of approximately 1,000 to 10,000 targeted aptamers aimed at specific alpha-conotoxins, palytoxins, and various viral targets, which are critical for the development of broad-spectrum DNA aptamers to neutralize toxins. Interested vendors may challenge this sole source determination by submitting a capability statement by 1300 Eastern Time on February 6, 2025, via email to the designated contacts, Christina Lewis and Jayme Fletcher, with no solicitation document currently available for this requirement.
    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research Department of Defense Dept. of the Army -- USAMRAA
    Dept Of Defense
    Special Notice: DEPT OF DEFENSE DEPT OF THE ARMY is seeking extramural research and development ideas for medical research. The USAMRDC aims to provide solutions to medical problems for the American Service Member and the general public. This BAA solicits basic and applied research projects to advance medical science and technology. The selection process is highly competitive, and submissions are accepted throughout a 5-year period. Pre-proposals must be submitted through the electronic Biomedical Research Application Portal (eBRAP), and invited full proposals must be submitted through Grants.gov.
    MTEC Solicitation Summary: Fiscal Year 2025 Multi Topic Request for Proposals
    Dept Of Defense
    The Department of Defense, through the Medical Technology Enterprise Consortium (MTEC), is soliciting project proposals for the Fiscal Year 2025 Multi-Topic Request for Proposals (RPP) aimed at advancing medical technologies relevant to military operations. Proposals must focus on one of the specified areas of interest, including infection prevention in battlefield wounds, treatment of sepsis, and musculoskeletal injuries, with an emphasis on military relevance and innovation in medical techniques and products. This initiative is critical for enhancing the readiness and effectiveness of military personnel in future conflicts, with potential funding amounts ranging from approximately $750,000 to $5 million depending on the focus area and project scope. Interested parties should direct inquiries to Chuck Hutti at chuck.hutti@ati.org and submit proposals in accordance with the guidelines available on the MTEC website, with the expectation of awards being made in FY 2025 and 2026.
    BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB
    Dept Of Defense
    Solicitation DEPT OF DEFENSE is seeking research and development services in support of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), JPM Medical and JPL EB. The service being procured is for the identification of the best available science in the areas of research interest, including novel solutions and improved methods for developing medical countermeasures. The government is specifically interested in enabling technologies, life cycle bioinformatics, and improved logistics tracking. The procurement notice is available on SAM.gov and the JPEO-CBD website. Potential offerors are encouraged to communicate with the JPMO technical contacts for proposal ideas. For any questions or inquiries, contact usarmy.detrick.mcs.mbx.baa@mail.mil.
    Food and Drug Administration (FDA) Regulatory Compliance Training
    Dept Of Defense
    The Department of Defense, through the U.S. Army Medical Research and Development Command (USAMRDC), is seeking qualified vendors to provide FDA Regulatory Compliance Training for personnel involved in FDA-regulated research activities. The training will focus on Good Clinical Practices (GCP), Good Laboratory Practices (GLP), current Good Manufacturing Practices (cGMP), and Quality Systems Regulations (QSR), ensuring that personnel maintain the necessary competency and compliance with U.S. FDA and Department of Defense regulations. This initiative is crucial for facilitating the development of FDA-approved pharmaceuticals and devices for military members, reflecting the government's commitment to research integrity and regulatory adherence. Interested vendors must submit a Capability Statement by February 5, 2025, and the anticipated contract will span one base year with four optional years, commencing around May 2025. For further inquiries, contact Matthew Gembe at matthew.w.gembe.civ@health.mil or call 301-619-1350.
    2026 NIAID DMID Omnibus Broad Agency Announcement
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting proposals for the 2026 DMID Omnibus Broad Agency Announcement (BAA) aimed at advancing research and development of medical countermeasures against antimicrobial-resistant pathogens and viruses with pandemic potential. The BAA encompasses two primary research areas: Research Area 001 focuses on developing therapeutics, vaccines, and diagnostics for antimicrobial-resistant bacterial and fungal pathogens, while Research Area 002 targets the creation of Direct Acting Antivirals for viruses of pandemic potential. This initiative is critical for addressing public health challenges related to infectious diseases, with an estimated funding of $28.5 million available for awards in fiscal year 2026. Proposals for Research Area 001 are due by February 21, 2025, and for Research Area 002 by January 21, 2025; interested parties can contact Swee L. Teo at teosl@niaid.nih.gov or Brian Madgey at brian.madgey@nih.gov for further information.
    FY2025-2034 DTRA Chemical and Biological Technologies Fundamental Research Broad Agency Announcement
    Dept Of Defense
    The Defense Threat Reduction Agency (DTRA) is inviting proposals for the FY2025-2034 Chemical and Biological Technologies Fundamental Research Broad Agency Announcement (BAA), aimed at advancing research to counter Weapons of Mass Destruction (WMD). This opportunity emphasizes collaborative efforts from accredited universities, industrial entities, and not-for-profit research organizations, focusing on innovative solutions in chemical and biological defense, including detection, diagnostics, and countermeasures against C-WMD threats. The BAA is crucial for enhancing national security and promoting STEM education, with funding anticipated for approximately 30 awards each year, ranging from $25,000 to $1 million annually. Interested applicants must submit pre-application white papers by February 7, 2024, and can contact the DTRA RD-CB FRBAA Mailbox at dtra.belvoir.rd.mbx.rd-cb-frbaa25-34-ta1@mail.mil for further information.
    Microbiological Identification/Susceptibility (ID/AST) testing support for the Landstuhl Regional Medical Center (LRMC), Germany
    Dept Of Defense
    The Department of Defense, through the Department of the Army, is seeking contractors to provide Microbiological Identification/Susceptibility (ID/AST) testing support for the Landstuhl Regional Medical Center (LRMC) in Germany. The procurement involves a Cost Per Test (CPT) basis for supplies and services related to organism sensitivity and identification, with a focus on timely delivery, installation, maintenance, and compliance with Clinical Laboratory Improvement Amendments guidelines. This contract is crucial for maintaining operational efficiency in laboratory services, ensuring high standards of testing and compliance with security protocols. Interested parties should note that the contract period spans from May 1, 2025, to September 30, 2029, and are encouraged to contact Henning Mayer-Goldstein at henningfalk.mayer-goldstein.ln@health.mil or Matthew R. Elden at matthew.r.elden.civ@health.mil for further details.
    ACC-APG Natick Division FY25 Upcoming Aquisitions
    Dept Of Defense
    The Department of Defense, through the ACC-APG Natick Division, is announcing upcoming acquisitions for Fiscal Year 2025, aimed at enhancing capabilities related to chemical, biological, radiological, and nuclear defense. The procurement includes a variety of requirements such as the purchase of a CISCO AMP firepower system, professional services, peptide synthesizers, and HVAC maintenance, with contract values ranging from $110,032 to $49,201,610. These acquisitions are crucial for supporting the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO CBRND) in its mission to ensure national security. Interested contractors can reach out to the Natick Division at usarmy.natick.acc-micc.mbx.ncd-internal-tasker@army.mil for further details, as the tentative award dates are set for early 2025.